NCT00660699

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

A Feasibility Phase II Study of Gemcitabine With Docetaxel With Concurrent 3-D Conformal Radiation Plus Continuous Infusion 5-Fluorouracil in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Washington University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To assess the feasibility of administering induction chemotherapy with gemcitabine and docetaxel followed by concurrent radiation and continuous infusion 5FU and consolidation gemcitabine/docetaxel chemotherapy.

Conditions

• Cholangiocarcinoma Cancer
• Gallbladder Cancer
• Pancreatic Cancer
• Ampullary Cancer

Interventions

Type	Name	Description
DRUG	Gemcitabine
DRUG	Docetaxel
RADIATION	Radiation

Timeline

• Start date: 2002-09-01
• Primary completion: 2010-09-01
• Completion: 2012-09-01
• First posted: 2008-04-17
• Last updated: 2015-05-27
• Results posted: 2015-05-27

Locations

1 site across 1 country: United States